Israel VC Funds

2150 is a London, Copenhagen, and Berlin-based venture capital firm focused on transforming urban environments through sustainable technology. With a €268 million fund, 2150 invests in companies that address major challenges across the "Urban Stack"—everything from the design and construction of cities to how they are powered and maintained. Their mission is to support groundbreaking startups that can reimagine urban living, while significantly reducing carbon emissions and improving sustainability. 2150 primarily invests in Series A and B stage companies, with check sizes ranging from $1 million to $7 million. Their focus spans climate tech, green solutions, and innovative materials, all aimed at creating smarter, more efficient cities. The firm’s portfolio includes companies like CarbonCure, which injects recycled CO₂ into concrete to reduce its carbon footprint, Normative, a platform that helps businesses track and manage their carbon emissions, and Ampd Energy, which electrifies construction sites to minimize pollution. Beyond financial backing, 2150 takes a hands-on approach, working closely with founders to scale their businesses and maximize impact. The firm’s ultimate goal is to build a portfolio capable of mitigating gigatonnes of CO₂ emissions, comparable to the entire annual output of countries like Germany and France. With strong backing from investors like Novo Holdings and the BMW Foundation, 2150 is positioned as a key player in the future of urban development, driving both commercial success and global sustainability.

27V (Twenty Seven Ventures) is a venture capital firm that focuses on early-stage investments in EdTech (education technology) and Future of Work startups. The firm was founded by Atin Batra and is headquartered in the Cayman Islands. Since its inception in late 2019, 27V has invested in 28 companies across regions including North America, Europe, and Asia Pacific (excluding India and China). 27V typically invests at the pre-seed and seed stages, with initial checks ranging from $50,000 to $250,000, and reserves funds for follow-on investments. The firm is more than just a fund; it promotes a "Founder Fellowship" that emphasizes community and connections among founders and their teams, facilitating shared learning and support. Notable investments in their portfolio include companies like Fluent, which aims to revolutionize language learning, and Preteckt, which uses machine learning to predict maintenance issues in vehicles. 27V's unique approach includes a scout network that helps identify promising startups from underrepresented communities, fostering diversity and inclusion in the venture capital ecosystem.

3M Ventures, the corporate venture capital arm of 3M, focuses on investing in early-stage companies that align with 3M's strategic priorities. These priorities include automotive electrification, safety, home improvement, consumer electronics, climate tech, sustainable packaging, industrial automation, and semiconductor and data center technologies. Their investment strategy targets companies with strong intellectual property, demonstrated commercial traction, and robust management teams​. Notable investments by 3M Ventures include GrayMatter Robotics, Moxe Health, and Metalenz, which span across artificial intelligence, healthcare, and 3D technology, respectively. 3M Ventures seeks to not only provide financial investment but also leverage 3M's extensive technological platforms, manufacturing capabilities, and global networks to help scale their partner companies​. 3M is also heavily committed to sustainability. The company has pledged $1 billion to achieve carbon neutrality, reduce water use, and improve water quality by 2030. This initiative includes implementing state-of-the-art water purification technology and developing innovative solutions for renewable energy and emissions reduction​.

415 Capital is a Munich-based venture capital firm that specializes in investing in breakthrough medical technologies, particularly those addressing critical unmet needs in cardiovascular and neurovascular diseases. With a focus on improving patient outcomes and reducing healthcare costs, 415 Capital invests in startups across Europe, Israel, and North America, typically writing checks between €5 million and €15 million per company. The firm’s portfolio boasts several cutting-edge companies like Supira Medical, which is developing a percutaneous ventricular assist device for high-risk heart patients, and Distalmotion, known for its innovative surgical robotics platform. 415 Capital avoids biotech, healthcare services, and wellness products, honing in exclusively on medtech innovations. Their strategy emphasizes deep involvement from the R&D stage through commercialization, leveraging close relationships with healthcare providers and access to a €2 billion commercial channel in Europe. The firm’s team combines expertise in investment, medical device commercialization, and clinical practice, ensuring they remain at the forefront of medical innovation. Historically, 415 Capital has been part of significant advancements such as the development of transcatheter heart valves and renal denervation technologies. Their approach to venture capital is deeply rooted in the belief that pioneering medical technologies can simultaneously improve healthcare and generate substantial returns.

83North is a global venture capital firm with over $2.2 billion in assets under management. Founded in 2006, the firm invests across various stages and sectors, with a focus on supporting exceptional entrepreneurs in building global category-leading companies. The firm operates with a philosophy that emphasizes deep involvement with portfolio companies, long-term relationships, and a lean operational structure, maintained by its four equal partners: Laurel Bowden, Gil Goren, Yoram Snir, and Arnon Dinur. 83North has a significant presence in the US, Europe, and Israel, investing in industries ranging from software and IT to fintech, healthcare, and consumer technology. Notable investments include companies such as Mirakl, Payoneer, Paddle, and Snappy. The firm prides itself on having helped create 14 unicorns and achieving 32 successful exits out of nearly 90 investments. Their investment strategy is grounded in the belief that venture capital is not a scalable business, but rather one that benefits from a focused, hands-on approach. This strategy allows 83North to maintain quick, transparent processes and build a high level of trust with their entrepreneurs.

Acadian Ventures is an early-stage VC firm that focuses on the future of work, helping to build technologies that make work better, more equitable, and productive. Founded in 2019 by Jason Corsello, Acadian Ventures targets pre-seed, seed, and early Series A companies globally, with an emphasis on work tech, particularly in areas like intelligent work applications, work infrastructure, and new regulatory and compliance solutions. The firm typically invests between $500K to $1M, often co-investing alongside other VCs, and prefers to "fast follow" rather than lead rounds. Their hands-on approach and deep industry expertise have garnered them a high reputation among founders, with portfolio companies such as TechWolf and Compa praising their value as advisors. Anchored by notable LPs like ServiceNow Ventures, Acadian recently closed its second fund, a $30M commitment, nearly tripling their assets under management. They pride themselves on being highly engaged investors, often joining company boards as observers to support founders​.

Accel is a renowned venture capital firm known for its strategic investments across various stages and sectors. Founded in 1983, Accel has played a pivotal role in the success of numerous high-profile companies. Some of its most notable investments include Facebook, Dropbox, Spotify, and Slack, showcasing its strength in identifying and backing transformative technology companies early on. The firm's investment strategy focuses on seed and Series A funding, ensuring deep engagement with startups from their inception. Accel emphasizes a collaborative approach, providing not just capital but also mentorship and strategic support to help entrepreneurs build market-defining businesses. This hands-on involvement has led Accel to lead investments in over 70% of its portfolio companies​. Accel operates globally, with key offices in Silicon Valley, London, and Bangalore, enabling it to tap into entrepreneurial talent worldwide. The firm has recently closed on several funds totaling $3.05 billion, aimed at supporting early-stage startups and growth rounds for more mature companies​​. In 2023, Accel made significant investments in companies like Blackpoint Cyber, Headway, and Cyera, reflecting its commitment to diverse sectors such as cybersecurity, mental health, and data protection​​. This broad sector focus, combined with a global investment perspective, positions Accel as a key player in the venture capital landscape, continuously driving innovation and supporting exceptional entrepreneurs around the world.

Acrew Capital is a venture capital firm founded in 2019 and headquartered in Palo Alto, California. The firm focuses on investing in companies across various stages, from early to growth stages, emphasizing diversity and transformative technology. Acrew Capital operates two primary funds: the Long Term View (LTV) fund, which targets early-stage investments, and the Diversify Capital Fund (DCF), which focuses on growth-stage companies. The LTV fund invests in early-stage companies, typically in the Seed to Series A stages, with check sizes ranging from $1 to $15 million. The DCF fund is designed for growth-stage investments, offering $10 to $20 million per investment. Acrew Capital's investment strategy prioritizes deep domain expertise, diverse perspectives, and long-term commitments to their portfolio companies. The firm's core thesis areas include financial services, cybersecurity, data, augmented reality, virtual reality, web 3.0, and cryptocurrency sectors. Acrew Capital's notable investments include companies like Eden Health, BlockFi, and CipherTrace. They have successfully exited several investments through mergers and acquisitions, demonstrating a strong track record in identifying and nurturing high-potential startups​. The leadership team at Acrew Capital is composed of experienced professionals like Lauren Kolodny, Mark Kraynak, and Asad Khaliq, who bring extensive experience in venture capital and entrepreneurship. The firm's commitment to diversity is reflected in its team composition and investment approach, with a significant portion of its leadership being women or people of color​.

Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GlaxoSmithKline (GSK) in 2013. The firm focuses on advancing bioelectronic medicines and enabling technologies. APVC is headquartered in Cambridge, Massachusetts, with additional offices in Scotts Valley, California. APVC invests in companies that leverage advances in hardware, computing, and material science to regulate neural or cellular activity, aiming to treat a range of chronic diseases. Notable portfolio companies include Cala Health, which develops non-invasive neuromodulation therapies for conditions like essential tremor; CVRx, known for its FDA-approved BAROSTIM NEO therapy for heart failure; and Neuspera Medical, which is developing minimally invasive neuromodulation therapies for overactive bladder. The firm takes a hands-on role on the boards of startups, providing strategic guidance and support. APVC has made 25 investments to date, with recent notable investments in Exo, which offers AI-enabled handheld ultrasound imaging, and MicroTransponder, which focuses on therapies for neurological conditions. APVC's investment approach emphasizes diversity and inclusion within the healthcare and entrepreneurial communities. The leadership team includes Imran Eba and Juan-Pablo Mas, who bring extensive experience in venture capital and biotechnology investments.

AENU is a venture capital fund that’s making waves by focusing on early-stage climate tech companies, aligning profitability with environmental and social impact. Based in Europe, AENU primarily invests in startups that tackle the climate crisis through innovations in energy transition, carbon economy, and sustainability. Their portfolio includes impactful companies such as Alcemy, Monta, Ocell, Trawa, and Hometree, which work on solutions ranging from low-carbon cement to intelligent energy management. With a geographic focus on Europe, especially the DACH region, Nordics, and the UK, AENU targets Seed and Series A investments, typically writing checks between €1-4 million. They often co-lead or lead rounds and always aim for board representation to ensure a strategic partnership. Their innovative Impact-as-a-Service (IaaS) offering helps portfolio companies scale while maintaining strong environmental, social, and governance (ESG) standards. Founded by Fabian Heilemann and Ferry Heilemann, AENU boasts a team of seasoned entrepreneurs and investors with a proven track record of scaling ventures. The fund is committed to systemic transformation within venture capital, pushing for stakeholder alignment and equitable growth. Startups looking to partner with AENU should expect a research-driven, high-impact approach, where both financial returns and climate outcomes are equally prioritized​.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

Aglaé Ventures is a global technology-focused investment firm established in 2017, with headquarters in Paris and offices in New York and San Francisco. The firm is backed by Agache (formerly Groupe Arnault), the principal investment vehicle of Bernard Arnault, the controlling shareholder of LVMH. Aglaé Ventures invests in fast-growing tech companies at all stages, from seed to pre-IPO rounds, with investment sizes ranging from €100K to €100MM. Notable investments by Aglaé Ventures include high-profile companies such as Airbnb, Slack, Spotify, and Lyft. The firm is sector-agnostic but concentrates on asset-light and scalable business models, particularly in marketplaces, SaaS, content platforms, consumer apps, and digitally native vertical brands. Aglaé Ventures emphasizes a long-term investment approach, providing flexible and enduring capital while supporting portfolio companies with expertise in growth management, brand building, digital marketing, and global expansion strategies. The firm also leverages its extensive network, including access to the LVMH ecosystem, to accelerate the growth of its portfolio companies. The team at Aglaé Ventures includes experienced investors and entrepreneurs like Miyuki Matsumoto, Managing Partner and Head of US Investments, and co-founders Cyril Guenoun and Antoine Loison. The firm prides itself on its simple investment terms and quick decision-making processes, making it an attractive partner for ambitious founders​.

Startup Nation Central is a dynamic venture capital hub, focusing on fostering innovation in Israel. The platform showcases various funds such as Evolution Venture Capital, Aleph, fresh.fund, Type5 Venture Capital, Magenta Venture Partners, Crossroad Venture Capital, and Summus Venture Capital. Evolution Venture Capital Fund targets revenue-generating small and medium-sized technology companies, offering up to $2 million investments with a strategic focus on telecommunication, software, and mobile applications​. Aleph, with $850 million under management, supports early-stage Israeli startups, investing in diverse sectors like SaaS, fintech, and cybersecurity. They tend to lead investment rounds, aiming for significant growth and global impact​. Fresh.fund is prominent in pre-seed investments, focusing on follow-on rounds, with investments ranging from $250K to $1M across over 30 startups​​. Type5 Venture Capital specializes in aerospace technology and deep tech ecosystems, investing in next-gen medical systems and quantum computing platforms with check sizes between $5M and $30M​. Magenta Venture Partners, backed by Japanese institutional investors, focuses on sectors such as IoT, smart mobility, and enterprise software, aiming for early to mid-stage investments​​. Crossroad Venture Capital Fund, managed by Allegro S. r.l., emphasizes sectors including medical devices, ICT, and renewable energy, leveraging a multinational network to add strategic value. Summus Venture Capital, based in Israel and Estonia, invests in disruptive startups at pre-seed and seed stages, with a notable portfolio in sectors like AI and cybersecurity​.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

Aleph VC, founded in 2013 and based in Tel Aviv, is a prominent venture capital firm focused on early-stage investments in Israeli entrepreneurs. With $850 million under management, Aleph specializes in sectors such as fintech, digital health, cybersecurity, AI, and machine learning. The firm aims to build impactful global brands by providing strategic guidance and access to global markets. Notable investments in Aleph's portfolio include Lemonade, a global insurance company powered by AI and behavioral economics; Melio, which offers digital payment tools for small businesses; and Nexar, a dashcam and edge-AI platform for improved driving. Aleph has also backed companies like Freightos, a digital freight marketplace, and Placer.ai, a leader in location analytics. Aleph's investment strategy typically involves seed and early-stage funding, with investment sizes ranging from $2 million to $12 million. The firm has a strong track record of successful exits, including the public offerings of companies like Lemonade and Monday.com, and acquisitions such as Raftt by Wiz. The team at Aleph is led by co-founders Michael Eisenberg and Eden Shochat, along with partners Yael Elad and Tomer Diari. They leverage their extensive network and expertise to help portfolio companies grow and succeed on a global scale. Aleph's focus on innovation and strong support for its portfolio companies has established it as a leading venture capital firm in Israel​.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Alliance Ventures is the strategic venture capital arm of the Renault-Nissan-Mitsubishi Alliance, one of the largest automotive groups globally. Launched in 2018, the fund focuses on investing in innovative startups that are transforming the future of mobility. With headquarters in Amsterdam and offices in key innovation hubs such as Silicon Valley, Paris, Yokohama, and Tel Aviv, Alliance Ventures targets early-stage companies developing technologies related to new mobility, autonomous driving, electric vehicles (EV), energy solutions, and connected services. The fund, with an initial capital of $200 million, primarily invests in Series A and B rounds, helping startups scale through strategic collaborations within the Alliance’s vast automotive ecosystem. Notable investments include companies like WeRide (autonomous driving in China), Enevate (battery technology), and The Mobility House (smart charging and energy storage). Alliance Ventures leverages its extensive network to provide not only capital but also partnerships and market access to accelerate startup growth. Led by a seasoned team, including General Secretary Véronique Sarlat-Depotte and Partner Ryan Armbrust, the fund actively supports startups through every growth phase, from early innovation to commercial scaling, aiming to integrate cutting-edge solutions into the Renault-Nissan-Mitsubishi operations.

Allianz X, the digital investment arm of Allianz Group, focuses on investing in digital growth companies relevant to insurance and asset management. Since its inception, Allianz X has grown its portfolio to over 25 companies with assets under management exceeding €2 billion. The firm has identified 12 unicorns within its portfolio, showcasing its strategic investment acumen. Headquartered in Munich, Allianz X supports companies primarily in the insurtech and fintech sectors, aiming to foster innovations that complement Allianz Group's core businesses. Their investment approach includes late-stage funding, helping mature companies reach their next growth milestones. Key portfolio companies include WeLab, a leading digital financial service provider in Asia, and Pie Insurance, a digital provider of workers' compensation insurance in the U.S. Allianz X has been involved in significant funding rounds, such as co-leading a $250 million Series F investment in Coalition, Inc., a cyber insurtech company, and leading funding for London-based fintech OpenGamma. Their strategy also includes facilitating collaborative partnerships within the digital ecosystem to drive innovation and growth​.

Alon MedTech Ventures is a leading venture capital firm based in Israel, focusing on the incubation and growth of early-stage medical device companies. Founded and chaired by Dr. Shimon Eckhouse, a well-known inventor and entrepreneur in the medical technology sector, Alon MedTech plays a critical role in advancing innovative healthcare solutions that aim to improve global well-being. The firm operates as part of Israel’s Innovation Authority incubator system, providing startups with not only financial backing but also strategic guidance, access to state-of-the-art facilities, and industry expertise. Alon MedTech's investment strategy emphasizes novel technologies that have the potential to revolutionize medical practices and patient outcomes. Alon MedTech’s portfolio includes a variety of groundbreaking companies, such as Hallura, which is developing next-generation hyaluronic acid dermal fillers using a unique crosslinking technology, and SofWave, which offers non-invasive skin tightening solutions using ultrasound technology. The firm’s approach is highly hands-on, working closely with entrepreneurs from the ideation stage through to commercialization, ensuring that these companies can scale successfully and impact the healthcare industry globally. The firm’s commitment to innovation and deep engagement with portfolio companies has positioned it as a key player in the medical device sector, particularly within Israel’s vibrant tech ecosystem.

AI Capital is a venture capital firm based in Denver, with operations spanning North America, Europe, and Asia. It focuses on early-stage investments in AI-driven companies, particularly in enterprise software and data platforms. The firm’s primary industry targets are healthcare, life sciences, and core industries like energy and manufacturing, where AI can optimize supply chains and critical services. Additionally, AI Capital invests heavily in cybersecurity, recognizing its importance across these sectors. The firm typically invests in Seed to Series B rounds, bringing a strong combination of technical expertise and deep investment experience. Recent notable portfolio companies include Link3D, Syndesis Health, and Luminoso. AI Capital emphasizes transformative AI applications, from VR therapy to advanced genomic solutions. They aim to support companies with high growth potential and significant societal impact. The firm is led by experienced partners like Neville Teagarden and Andrew Maus, with a team composed of AI specialists and seasoned investors. They value companies solving real-world problems through breakthrough AI technologies. AI Capital often leads rounds and is known for being highly involved with its portfolio companies, offering both strategic and operational support. Founders are encouraged to approach them through established networks or referrals, particularly those innovating in AI's frontier sectors.

Alpine VC targets founders who are relentless about their products and users, focusing on companies in consumer tech, prosumer software (including tools for creators and developers), and software designed for SMBs. Alpine prioritizes product-led growth (PLG) startups and seeks companies whose products directly resonate with and serve their customers effectively. With typical check sizes from $250,000 to $1 million, they invest at the seed and Series A stages, comfortable leading, co-leading, or joining larger syndicates for flexible collaboration. Alpine operates globally but is rooted in Alameda, California. They emphasize founder passion over traditional metrics like education or professional background, valuing founders who live and breathe their products and who demonstrate an unwavering commitment to the user experience. Alpine’s strategy revolves around building strong, supportive relationships with founders, aiding in everything from go-to-market strategies to operational scaling and customer engagement. The Alpine team is known for its user-centered investment approach, thinking from the perspective of the end user to drive meaningful product development. They encourage founders to pitch directly, favoring those with a clear vision, deep product insights, and a strong connection to their target market. This lean, founder-focused approach allows Alpine to spot high-potential opportunities and help guide early-stage companies through pivotal growth stages, making Alpine an ideal partner for innovative, product-driven startups seeking flexible, strategic support.

AM Ventures is a leading venture capital firm focused on the industrial 3D printing sector, also known as additive manufacturing. Established in Germany, AM Ventures supports early-stage startups worldwide that are innovating in areas such as materials, software, hardware, and applications related to 3D printing. The firm is renowned for its deep industry expertise and extensive global network, which spans 13 countries across four continents. The firm’s investment strategy is centered on empowering entrepreneurs who are developing next-generation technologies that can address major global challenges, including climate change, medical advancements, and digital manufacturing. AM Ventures typically invests between €500,000 and €3 million, focusing on companies from the seed stage to growth phases. In 2022, AM Ventures launched a €100 million venture capital fund dedicated to furthering its commitment to industrial 3D printing. This fund is the first of its kind, emphasizing the firm’s leadership in the additive manufacturing industry and its dedication to driving sustainable innovation on a global scale. The firm partners closely with its portfolio companies, offering not just financial backing but also strategic support and industry connections to help these startups thrive.

Amadeus Capital Partners is a prominent global venture capital firm based in London, established in 1997 by Anne Glover and Hermann Hauser. The firm has built a strong reputation for investing in high-growth technology companies across various sectors, including artificial intelligence, cybersecurity, digital health, fintech, and semiconductors. Amadeus Capital Partners focuses on different stages of investment, providing seed, early-stage, and growth capital to companies with the potential to become global leaders. They are particularly interested in businesses with innovative intellectual property (IP) and those addressing significant, underserved market needs. The firm supports its portfolio companies with both capital and strategic guidance, aiming to build companies that can expand globally. Some of the notable investments include companies like Riverlane, which focuses on quantum computing, and Graphcore, known for its AI hardware solutions. Amadeus Capital Partners has made over 340 investments and has successfully exited over 110 companies, including high-profile exits such as Lumeon and Brytlyt. The firm’s investment approach emphasizes backing great teams, fostering innovation in billion-dollar markets, and scaling businesses to achieve global impact. With a team of over 40 professionals and a strong network of co-investors, Amadeus continues to be a significant player in the venture capital landscape, driving technological advancements across various industries​.

The Amazon Industrial Innovation Fund (AIIF) is Amazon’s $1 billion venture fund focused on advancing technologies that reshape fulfillment, logistics, and supply chain sectors. Established in 2022, the fund invests in companies across various stages, from startups to established players, that bring innovative solutions to areas like warehouse automation, robotics, and artificial intelligence. AIIF's goal is to enhance Amazon’s operations, with an emphasis on employee safety, efficiency, and customer satisfaction. Under the leadership of Franziska Bossart, the fund is expanding its scope in 2024 to target additional areas such as autonomous vehicles and last-mile delivery tech. Key investments have included companies like Agility Robotics, which develops bi-pedal robots for warehouse operations, and Vimaan, specializing in computer vision for inventory management. AIIF’s investments in companies such as Modjoul, which creates wearable safety devices, highlight its commitment to fostering technologies that support workplace safety while advancing automation. AIIF aims to support high-quality companies globally, not limited to Amazon's internal needs, as it seeks broader improvements in industrial automation and supply chain management. This makes AIIF a significant player in the field of corporate venture capital, uniquely positioned to drive impactful innovations while improving Amazon’s logistics capabilities and operational safety.

Amiti Ventures is a prominent deep-tech seed-stage VC firm based in Israel, known for investing in transformational technologies that promise to reshape industries. Amiti focuses on early-stage companies developing innovations in sectors such as AI, semiconductors, computational biology, quantum computing, and cybersecurity. Their portfolio includes companies like Innoviz, a leader in autonomous vehicle LiDAR technology, and Vayyar Imaging, which has expanded its groundbreaking radar tech across healthcare and automotive markets. Amiti’s investment strategy is forward-looking, targeting disruptive technologies that are years ahead of market trends. They are patient investors, often backing technologies that require long development cycles. They take a hands-on approach, supporting founders not just with capital but with strategic advice, business development, and their extensive global network. The firm predominantly invests in Israeli startups, leveraging Israel’s tech talent to identify world-class founders. Founders can expect personalized support through Amiti’s strong community and partnership network, and they actively promote diversity in their portfolio. Amiti also runs a “Nurture” program, designed to help tech innovators transition into entrepreneurship by providing foundational knowledge and access to a broader support network. Led by Ben Rabinowitz and a diverse team, Amiti offers significant value beyond financial investment, helping companies navigate the challenges of scaling cutting-edge technologies. They frequently lead funding rounds and remain deeply engaged with their portfolio companies, ensuring a balance between long-term vision and strategic execution.

Angelini Ventures is the corporate venture capital arm of Angelini Industries, founded in 2021 and headquartered in Rome, Italy. With a capital commitment of €300 million, Angelini Ventures focuses on early-stage investments in biotechnology, digital health, and life sciences. The firm aims to leverage technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations. The firm has made significant investments globally, including in Europe, North America, and Israel, with a particular emphasis on brain health and consumer segments such as women, children, and the elderly. Notable portfolio companies include Pretzel Therapeutics, Argobio, Serenis, and Nouscom. Angelini Ventures is led by CEO Paolo Di Giorgio, who has extensive experience in the pharmaceutical and investment sectors. The team includes experts such as Elia Stupka, Managing Director, and Gabriela Manrique, Partner, among others, spread across major innovation hubs globally​.

Anterra Capital is a venture capital firm that specializes in investments within the food and agricultural technology sectors. Founded in 2013, Anterra Capital has offices in Amsterdam and Boston and focuses on backing innovative companies that address critical challenges in agriculture, food production, and sustainability. Their portfolio includes notable investments such as Enko Chem, which develops novel crop protection products; ProducePay, a financial and data services platform for the fresh produce industry; and BiomEdit, which focuses on microbiome innovation for animal health. The firm manages over $450 million in assets and typically invests in Series A or B rounds, with initial checks ranging from $1 to $10 million. Anterra is committed to leveraging biotechnology and digital solutions to transform the food system, improve consumer health, and enhance the livelihoods of farmers. Their investment strategy emphasizes impact and sustainability, aligning with their goal to create a resilient and sustainable food system. Anterra Capital has raised significant funds, including a $260 million second Global Food and Agriculture Technology Fund, which continues to support biotech and digital innovations in the agrifood sector​.

Antler is a globally renowned early-stage venture capital firm known as the "day zero investor," backing founders from the inception of their startups. With over 850 investments in 20+ countries, Antler has notable portfolio companies like Airalo, a global eSIM provider, and has recently raised a $60 million MENAP fund to further support startups in the Middle East, North Africa, and Pakistan region. Antler focuses on sectors including technology, fintech, and digital innovation, providing personalized coaching, co-founder matching, and follow-on funding. Key team members include Dr. Jonathan Doerr and Romain Assunção, leading regional activities from Riyadh and Duba

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

APEX Ventures is a venture capital firm based in Vienna, Austria, specializing in deep tech and medical technology startups. Founded in 2016, APEX Ventures invests in early-stage companies across Europe, with a focus on innovations in AI, quantum computing, automation, robotics, computer vision, space technology, and medical technology. The firm emphasizes backing startups with unique, defensible technologies that have the potential to disrupt and transform their respective industries​. In 2023, APEX Ventures partnered with Amadeus Capital Partners to launch the Amadeus APEX Technology Fund, which aims to raise €80 million to support deep tech startups primarily in the DACH region (Germany, Austria, and Switzerland). This fund focuses on seed and Series A investments, typically ranging from €1 million to €1.5 million. The partnership combines APEX’s local expertise and network with Amadeus’ extensive global experience in venture capital. APEX Ventures has a diverse portfolio, including companies like contextflow, ImageBiopsy Lab, and Mobius Labs. The firm is known for providing not just capital but also strategic support, leveraging their deep tech expertise and strong networks to help startups scale and succeed​.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, one of the world’s largest integrated energy and chemicals companies. Established in 2012, the fund has grown significantly, recently receiving an additional $4 billion, bringing its total capital to $7.5 billion. This expansion supports Aramco's long-term strategy of investing in technologies critical to energy transition and sustainability. Aramco Ventures operates through several specialized funds, including its Prosperity7 and Sustainability Fund, focusing on sectors such as carbon management, hydrogen, renewables, AI, and advanced materials. The firm has made over 140 investments globally, backing companies like Promethean Particles and Seeq that align with its strategic goals of advancing low-carbon and innovative technologies. The fund is headquartered in Dhahran, Saudi Arabia, and led by CEO Mahdi Aladel. It actively seeks out companies that can contribute to the global energy transition, emphasizing technologies that offer scalable solutions to the challenges facing the energy sector today​.

Aravis is a private equity firm based in Zurich, Switzerland, founded in 2001 by Jean-Philippe Tripet. The firm focuses on high-tech growth investments, primarily in the biotech, creative and digital, and industrial high-tech sectors. Aravis has sponsored multiple fund vintages and has deployed over USD 400 million across four funds. Aravis Growth I LP, their latest initiative, targets investments in established, innovative Swiss and European companies with significant growth potential. This fund aims to fill the gap in growth capital in the region by offering strategic advice, access to networks, and capital to accelerate companies through their growth phases​. The team at Aravis is composed of experienced professionals from various backgrounds, including finance, industry, and technology, providing a wealth of knowledge and expertise to support their portfolio companies. Their investment approach also integrates ESG criteria, aligning with several UN Sustainable Development Goals (SDGs).

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Arix Bioscience is a global venture capital firm based in London, specializing in biotechnology investments. Founded in 2016, Arix focuses on backing early-stage companies that are developing breakthrough treatments and technologies in the life sciences sector. Their investment strategy targets ventures from late pre-clinical to clinical stages, emphasizing a diversified portfolio to mitigate risks inherent in biotech investments​. The firm has built a robust portfolio that includes companies like Autolus, a developer of CAR-T cell therapies for cancer, and Disc Medicine, which focuses on treatments for hematologic diseases. Arix has also been involved in significant financing rounds, such as the $50 million Series B for Evommune and Ensoma, highlighting their role in advancing innovative biotech startups. Arix operates a permanent capital model, allowing it to support its portfolio companies through market fluctuations without being bound by strict exit timelines. This approach enables them to provide sustained support to their investments, which is critical in the high-risk, high-reward biotech sector.

Arkley Brinc VC is a venture capital firm based in Warsaw, Poland, that focuses on early-stage investments in hardware-enabled startups, particularly in IoT, MedTech, and smart manufacturing sectors. The firm was established as a joint initiative between Arkley, a European pioneer in hardware investments, and Brinc, a global accelerator known for its deep connections in China’s manufacturing hubs. This partnership allows Arkley Brinc to offer startups not only capital but also a wealth of resources for product development, manufacturing, and global distribution. With a fund size of $15 million, Arkley Brinc invests up to $1 million per company, supporting them from the prototype stage through to IPO. The firm’s investments are concentrated in Poland and across Europe, leveraging its strategic networks to help startups scale effectively. Arkley Brinc has a strong track record, with over 50 projects supported and several successful exits and IPOs. The firm’s team consists of serial entrepreneurs and finance professionals with extensive experience in launching and scaling technology businesses. The Arkley Launchpad program is another key initiative, offering a highly individualized acceleration program designed to raise successful funding rounds and drive operational success. This program is tailored to the specific needs of each startup, providing access to a network of partners in prototyping, manufacturing, sales, and investment.

Asahi Kasei Ventures is the corporate venture capital arm of Asahi Kasei, a diversified Japanese conglomerate with major operations in materials, homes, and healthcare. The venture fund focuses on early-stage investments globally, with a particular emphasis on startups that align with Asahi Kasei's strategic interests, such as advanced materials, healthcare innovations, and sustainability technologies. The fund is particularly active in sectors like hydrogen energy, carbon management, and bio-based chemicals, supporting startups that contribute to environmental sustainability. Asahi Kasei Ventures operates from key locations including Tokyo, Düsseldorf, and Shanghai, ensuring a broad geographic reach to identify and support innovative technologies worldwide. Asahi Kasei Ventures not only provides financial support but also leverages the vast resources and expertise of the broader Asahi Kasei Group, which has over 287 subsidiaries and a significant global footprint. This enables startups in their portfolio to benefit from deep industry knowledge, extensive networks, and strategic partnerships to accelerate their growth and impact.

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

AstraZeneca is a leading global biopharmaceutical company with a strong focus on oncology, biopharmaceuticals, and rare diseases. They are committed to discovering, developing, and delivering innovative medicines that transform the lives of patients worldwide. AstraZeneca's oncology portfolio is particularly noteworthy, with a significant emphasis on creating groundbreaking cancer treatments. Their strategy includes leveraging various scientific platforms such as antibody-drug conjugates (ADCs), radioconjugates, and T cell engagers. Recent high-profile deals include collaborations with Daiichi Sankyo for ADCs and the acquisition of Neogene Therapeutics to enhance their T cell receptor therapy capabilities​​. In addition to oncology, AstraZeneca has a robust pipeline in biopharmaceuticals aimed at addressing chronic diseases and enhancing long-term health outcomes. They are also advancing treatments for rare diseases, expanding their reach globally to ensure broader access to their innovative therapies​​. AstraZeneca's business development approach is integral to their growth, focusing on strategic alliances and partnerships. This includes collaborations with companies like Tempus for AI-enabled precision medicine and various biotech firms to accelerate advancements in areas like epigenetics and undruggable targets​​. The company emphasizes a culture of innovation, diversity, and sustainability, aiming to make a significant impact on global health while maintaining environmental responsibility through initiatives like Ambition Zero Carbon​.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

Atooro Fund is a venture capital firm based in Tel Aviv, Israel, established in 2016. It focuses on investing in seed, early-stage, growth-stage, and later-stage companies. The fund primarily targets sectors such as information technology, cybersecurity, food technology, agricultural technology, artificial intelligence, and machine learning. The fund supports innovative entrepreneurs and helps them build global companies. Atooro Fund’s investment strategy involves backing startups that bring significant advancements in their respective fields. Notable investments include Beewise, which specializes in autonomous beehive technology, QuantHealth, and Wisor AI, which operates in the AI and machine learning domains. The firm is led by Jacob Engel, who serves as the Chairman, and Yonatan Brender, the General Managing Partner. Engel is known for his extensive background in various industries, including mining and real estate, while Brender brings a wealth of experience in venture capital and technology investments. Atooro Fund aims to foster innovation and growth by providing not only financial support but also strategic guidance and resources to its portfolio companies, ensuring they can navigate challenges and achieve sustainable growth.

Autotech Ventures, based in Menlo Park, California, is an early-stage venture capital firm with a mission to solve global ground transportation challenges through technology. The firm manages over $500 million and invests in startups from seed to Series C stages that focus on connectivity, autonomy, shared-use, electrification, and digitization of enterprises. Autotech Ventures has an impressive portfolio that includes notable investments such as Lyft, Cazoo, SpotHero, Volta, and Outdoorsy. They have a history of successful exits, including Bear Flag Robotics, acquired by John Deere, and nuTonomy, acquired by Delphi. Their investment strategy often involves initial investments ranging from $1 million to $8 million, and they are known for their deep industry expertise and strong network within the transportation sector. The team, led by managing directors Quin Garcia and Daniel Hoffer, combines decades of experience in both the ground transport and venture capital industries. This allows them to identify and support startups that have the potential to disrupt traditional transportation models or introduce significant innovations in the field. Autotech Ventures prides itself on a founder-first philosophy and actively supports its portfolio companies by leveraging its extensive network of industry insiders, including fleet operators, vehicle manufacturers, and energy companies. This approach not only helps startups gain critical industry connections but also facilitates strategic partnerships and acquisitions.

Avant Global is a relationship-driven private investment firm founded in 1999, focused on leveraging high-level connections to foster innovative and high-growth companies. The firm has a global presence with offices in the USA, Greece, and the Philippines, and invests across various sectors including technology, healthcare, real estate, and consumer products​. Notable portfolio companies include The Healing Company, which focuses on healthcare and retail, Equiam, specializing in venture capital and asset management, and Jawbone Health, an information services and wellness company. Other significant investments are in innovative firms like Iron Ox, a leader in agricultural robotics, and BlueLayer, a software company based in Berlin​. The firm's founder and CEO, Demetri Argyropoulos, is known for his extensive network and strategic vision, having co-founded and invested in over 100 companies. He leads a seasoned team, including Executive Director George Vassilaras, who brings decades of experience in diverse industries and geographies​.

Aves Lair is a global venture capital and venture operator founded in 2020, specializing in supporting early-stage startups in the blockchain, AI, Web3, and digital asset sectors. Initially launched as a technology hub in 2018, Aves Lair has evolved into a comprehensive ecosystem that combines venture capital, acceleration, and hands-on operational support to foster growth and innovation. The firm operates with a “founder-first” approach, offering more than just financial backing. Through its in-house accelerator and incubation programs, Aves Lair captures startups at an early stage, providing critical resources such as fundraising assistance, technical development through in-house engineering teams, and strategic market access. The firm also supports its portfolio companies by securing board seats and guiding them through cross-border expansions. Aves Lair invests in projects that focus on the adoption of digital assets and disruptive technologies, with a strong network across Asia, Africa, and North America. Its portfolio includes companies like Computecoin and Digital Prime Technologies, which benefit from tailored support in everything from product development to scaling in global markets​.

Avid Ventures is a venture capital firm focused on backing early-stage startups in fintech, consumer internet, and software sectors across North America, Europe, and Israel. Founded in 2020 by Addie Lerner, formerly of General Catalyst, Avid invests primarily at Seed, Series A, and Series B stages. With a $68 million debut fund, Avid’s flexible approach allows for varied check sizes, co-leading rounds or making smaller initial investments alongside other top-tier investors. What sets Avid apart is its deep involvement in the strategic growth of its portfolio companies. The team, which includes key members like Tali Vogelstein and Irene Gendelman, works closely with founders, providing hands-on support in areas like financial modeling, business development, hiring, and fundraising strategy. Their approach is highly collaborative, with Avid acting as a dedicated extension of the startup’s team, offering outsourced strategic finance support and helping companies scale operationally. Avid’s portfolio includes a diverse range of innovative companies, such as Rapyd, a global payments platform, Nova Credit, a cross-border credit data provider, and Coast, a fintech startup. The firm is known for its founder-first mentality, emphasizing long-term partnerships and building trust through early involvement and continued support throughout the company's growth journey. This unique blend of flexibility, strategic involvement, and strong partnerships makes Avid Ventures a highly sought-after investor for transformative, high-growth startups.

AXA Venture Partners (AVP) is a global venture capital firm with more than €2 billion in assets under management. Founded in 2015, AVP focuses on investing in high-growth, technology-enabled companies across various stages, from early to late growth. Their investment sectors include enterprise software, fintech/insurtech, digital health, and consumer technology. Notable investments in AVP's portfolio include companies like Phenom People, Security Scorecard, and Virtuo. The firm leverages its connection with AXA, providing portfolio companies access to AXA’s global networks and expertise in risk management and financial services. This unique relationship allows AVP to offer significant business development support, shortening sales cycles and expanding market reach for their portfolio companies. AVP operates globally from offices in New York, London, and Paris. Their investment strategy is characterized by a multi-stage approach, focusing on product-market fit and initial traction in venture stage investments, and seeking companies with robust customer bases and significant revenue growth in growth stage investments. The leadership team includes François Robinet, the founder and managing partner, and other experienced partners such as Elizabeth de Saint-Aignan and Alex Scherbakovsky, who bring extensive expertise in technology and venture capital. For startups, AVP values exceptional founders with innovative solutions that can transform industries. Their support goes beyond financial backing, providing strategic guidance and leveraging their extensive network to help companies grow and succeed.

B Capital Group, founded in 2015 by Eduardo Saverin, Raj Ganguly, and Howard Morgan, is a global multi-stage investment firm. The firm focuses on investing in technology, healthcare, and climate sectors, supporting companies from seed to late-stage growth. With $7+ billion in assets under management, B Capital operates out of eight global locations, including New York, San Francisco, Los Angeles, Singapore, Beijing, and Hong Kong. B Capital's portfolio includes over 160 companies. Notable investments are in firms like Icertis, an AI-powered contract lifecycle management platform; Synack, a crowdsourced cybersecurity testing platform; and Khatabook, a digital bookkeeping solution for small businesses. These investments reflect B Capital's focus on transformative technologies that have the potential to reshape industries. The firm leverages its strategic partnership with Boston Consulting Group (BCG) to provide portfolio companies with expert advice, operational support, and strategic connections, helping them scale efficiently and effectively across global markets. B Capital's recent initiatives include the closure of their third growth fund series at $2.1 billion, emphasizing their commitment to supporting high-growth startups in the enterprise, fintech, and healthcare tech sectors. B Capital's investment approach is characterized by value-add investing, where they offer comprehensive support throughout the business development lifecycle. This includes advisory services on entering new markets, talent acquisition, and strategic business development, ensuring their portfolio companies achieve sustainable growth and success.

BAE Systems is a global leader in defense, aerospace, and security solutions, employing around 100,000 people across 40 countries. The company focuses on developing advanced technology solutions to protect national security and provide military capability worldwide. BAE Systems' strategy revolves around maintaining and growing its core businesses, which include electronic systems, platforms, and services, while also expanding into emerging markets such as robotics, AI, and cybersecurity. The company is deeply involved in the development of unmanned systems, including autonomous vehicles and drones, which are integrated into tactical communications networks to enhance battlefield effectiveness. The company is also committed to sustainability, with initiatives aimed at achieving net-zero operations by 2030. BAE Systems is investing in innovations that not only enhance military capabilities but also contribute to environmental sustainability, such as energy-efficient platforms and carbon management technologies. In the robotics sector, BAE Systems has been particularly active, filing multiple patents related to unmanned systems and autonomous vehicles, reflecting its focus on maintaining technological superiority in defense and security.